What lab tests are recommended to rule out Cushing's (Cushing's syndrome) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lab Tests to Rule Out Cushing's Syndrome

To rule out Cushing's syndrome, perform at least two of three first-line screening tests: 24-hour urinary free cortisol (UFC), late-night salivary cortisol (LNSC), or overnight 1-mg dexamethasone suppression test (DST), with UFC and LNSC being preferred for their superior sensitivity (>90%) and specificity (approaching 100%). 1

Recommended Screening Tests

First-Line Options (Choose at Least 2)

  • 24-hour urinary free cortisol (UFC): Collect for 3 consecutive days with diagnostic cutoff >193 nmol/24h (>70 μg/m²), demonstrating 89% sensitivity and 100% specificity 1. Values >100 μg/24h (1.6 μmol/24h) are typically diagnostic in symptomatic patients 1. When measured by LC-MS/MS, UFC achieves the best accuracy among screening tests with positive likelihood ratio of 10.7 and negative likelihood ratio of 0.03 2.

  • Late-night salivary cortisol (LNSC): Obtain samples on 2-3 separate nights with abnormal threshold >3.6 nmol/L, achieving 95% sensitivity and 100% specificity 1. This test has the highest specificity among screening modalities 3 and is particularly useful for outpatients since cortisol is stable at room temperature 4.

  • Overnight 1-mg dexamethasone suppression test (DST): Administer 1 mg dexamethasone at midnight with serum cortisol measured at 8 AM; values >1.8 μg/dL (50 nmol/L) indicate Cushing's syndrome 1. Cortisol >5 μg/dL (138 nmol/L) indicates overt disease 3. This test has >90% sensitivity and is particularly effective for ruling out the condition when negative 5.

Critical Testing Principles

  • Never rely on a single test: Perform at least 2-3 abnormal screening tests before confirming the diagnosis, as no single test achieves 100% diagnostic accuracy 1. This is especially important because 24-hour UFC can vary by up to 50% between collections 1.

  • Exclude exogenous glucocorticoid use before any biochemical testing, including oral prednisolone, dexamethasone, and fluticasone inhalers, as these confuse interpretation 1, 3.

Diagnostic Algorithm

  1. Initial screening: Order at least two of the three first-line tests (UFC, LNSC, DST) simultaneously 1

  2. If results are discordant: Obtain 2-3 additional collections of each test to account for variability and cyclic disease 1, 3

  3. If ≥2 screening tests are abnormal: Measure morning (09:00h) plasma ACTH to determine if Cushing's syndrome is ACTH-dependent (ACTH >5 ng/L) or ACTH-independent (low/undetectable ACTH) 1

  4. If ACTH is normal/elevated: Proceed to pituitary MRI 1

Common Pitfalls to Avoid

Factors Causing False-Positive Results

  • Oral contraceptives and estrogen therapy: Increase cortisol-binding globulin, falsely elevating total cortisol 3. Consider alternative tests or discontinue estrogen before testing 5.

  • CYP3A4 inducers: Accelerate dexamethasone metabolism, causing false-positive DST results 3. Consider measuring dexamethasone levels concomitantly with cortisol to confirm adequate drug absorption 1, 5.

  • Pseudo-Cushing's states: Depression, alcoholism, severe obesity, and polycystic ovary syndrome can cause mild hypercortisolism mimicking true disease 3. Consider Dex-CRH test to distinguish if results remain equivocal 1.

  • Night-shift workers: Should not undergo LNSC testing due to disrupted circadian rhythm 3. DST may be preferred in this population 5.

Factors Causing False-Negative Results

  • CYP3A4 inhibitors: Increase dexamethasone levels, causing false-negative DST results 3

  • Renal impairment or polyuria: Invalidate UFC results; use LNSC instead 3

  • Cyclic Cushing's syndrome: Can produce weeks to months of normal cortisol secretion interspersed with excess, requiring extended monitoring during symptomatic periods 1, 3

Collection Issues

  • Incomplete 24-hour urine collection: Measure volume and total creatinine excretion to assess completeness 1. Avoid copper contamination of collection apparatus 1.

  • Salivary cortisol contamination: Avoid dental work, teeth brushing, or oral trauma within 1-2 hours of collection 3. Topical hydrocortisone preparations can contaminate samples 3.

Special Populations

Children and Adolescents

  • Use the same three screening tests with age-appropriate cutoffs: UFC >193 nmol/24h (>70 μg/m²), midnight sleeping cortisol ≥50 nmol/L (≥1.8 μg/dL), or LNSC based on local assay cutoff 1

  • Low-dose dexamethasone suppression test (LDDST): 0.5 mg 6-hourly for 48 hours, with serum cortisol >50 nmol/L (>1.8 μg/dL) indicating Cushing's syndrome 1

Adrenal Incidentalomas

  • DST is particularly useful as first-line test, with cortisol values >5 μg/dL identifying patients with dysregulated cortisol secretion 5

References

Guideline

Diagnostic Approach to Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.

The Journal of clinical endocrinology and metabolism, 2015

Guideline

Cortisol Levels and Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cushing's Syndrome: Screening and Diagnosis.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2016

Guideline

Diagnosing Cushing's Syndrome with Dexamethasone Suppression Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.